| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |